Authors
Latest:
CDC Report Highlights Current Trends in Opioid PrescriptionsThe recently released CDC Annual Surveillance Report of Drug-Related Risks and Outcomes presents a clearer picture for how has opioid prescribing been trending in the last 3 years.
Latest:
Opinion: The Opioid Crisis: Where Does Pharma Go From Here?After the Oklahoma case ruling, Johnson & Johnson stocks rallied, but the ruling is a warning to industry leaders that change is necessary.
Latest:
Sharps Disposal: Assuring Regulatory Compliance During Off-Site Vaccination ClinicsInnovative pharmacists have taken immunizations, including the influenza vaccine, to off-site clinics located at employer sites, churches, malls, and various other community locations, with the intent to keep people healthy during the annual flu season rather than having them experience extended illnesses and loss of productivity.
Latest:
Cost Outcomes of Diabetes Education in a Specialized Community PharmacyDiabetes management offered by an employer group in a self-funded health plan over 3 years resulted in significant cost savings and improved patient outcomes.
Latest:
Lung Cancer: Copayments and Behavior Following Erlotinib Formulary Tier ChangeMoving erlotinib from formulary tier 3 to tier 2 resulted in lower copayments and higher treatment persistence among lung cancer patients.
Latest:
The Impact of PCSK9 Inhibition in Dyslipidemia ManagementThis Continuing Education activity is supported by an educational grant from Amgen.
Latest:
Top 200 Drugs of 2018: Which Ones Are Making an Impact?The latest DrugStats database list shows the medications with increasing numbers of prescriptions.
Latest:
How Biomarkers Can Improve Early Diagnosis of Multiple SclerosisA lack of biomarkers can result in a delay in multiple sclerosis diagnosis and treatment.
Latest:
The Challenge of Specialty Pharmacy: Mitigating Costs While Providing Quality CareThe cost of complex therapies is soaring, and the challenge is to deliver access to these medications in the most cost-effective and clinically appropriate site of service.
Latest:
New Insulin Products and Best PracticesEven with many new developments over the past century, the coordinated use of blood glucose monitors, diabetes medications, and insulin to manage the disease may be too intricate for some patients.
Latest:
NAPLEX Preparation: Tips for the Most Important Exam of Your CareerBefore you start preparing for NAPLEX, familiarize yourself with what to expect for the exam.
Latest:
A Look Back and at What Lies Ahead for Specialty Pharmacy in 2019There is no doubt that 2018 was a year of transformation across the health care spectrum, and specialty pharmacy was no exception.
Latest:
Out-of-Pocket Healthcare Expenditures and Caps in Patients With Chronic ConditionsA small proportion of patients with chronic conditions have very high healthcare expenditures, and a trend was observed toward increasing coinsurance requirements.
Latest:
Natural Products on Deck: Keeping Joints in the GameMany patients with osteoarthritis turn to complementary and alternative medicine, either as an adjunct to prescription therapy or to avoid side effects.
Latest:
Passing the First Test: How to Impress on the Residency InterviewWith more and more students applying for residency positions, off-site interviews are becoming an important first step in the selection process.
Latest:
Improving Adherence With Immunization SchedulesAs a whole, adult vaccination coverage has remained unchanged without significant improvement.
Latest:
Impact of Antidepressant Therapy on Statin Adherence and Cholesterol ControlAmong patients with poor statin adherence, adequate antidepressant treatment significantly improved adherence and persistence compared with inadequate or no antidepressant treatment.
Latest:
OTC, Prescription Drug Abuse Increasing Among AdolescentsNeighborhood pharmacists can provide support and information.
Latest:
Christiana Care Implements Formulary Decision Process Focused on ValueThe new process takes into account the efficacy, risk, cost, and societal benefit of a given specialty drug in determining whether it should be added to the hospital's formulary.
Latest:
Sodium-Glucose Cotransporter-2 Inhibitors for Treating Type 2 DiabetesDiabetes is a complex disease affecting 29.1 million individuals in the United States.
